Patents by Inventor E. Huber

E. Huber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240420746
    Abstract: A memory device includes a command interface configured to receive write commands from a host device. Additionally, the memory device includes an input buffer configured to buffer a strobe signal from the host device. Furthermore, the memory device includes a first ripple counter and a second ripple counter. The memory device includes command handling circuitry configured to alternatingly start the first ripple counter and the second ripple counter in response to consecutive write commands. The command handling circuitry and/or the first and second ripple counters are configured to suppress a reset of the input buffer if either the first ripple counter or the second ripple counter has not reached a threshold and is still counting.
    Type: Application
    Filed: August 26, 2024
    Publication date: December 19, 2024
    Inventors: Brian W. Huber, Scott E. Smith, Gary L. Howe
  • Publication number: 20240399523
    Abstract: Power tools described herein include a housing, a motor supported by the housing, a battery pack configured to provide electrical power to the power tool, a user input configured to provide an input signal corresponding to a target speed of the motor, a plurality of sensors supported by the housing and configured to generate sensor data indicative of an operational parameter of the power tool, and an electronic controller. The electronic controller includes an electronic processor and a memory. The memory includes a machine learning control program for execution by the electronic processor. The electronic controller is configured to receive the target speed, receive the sensor data, process the sensor data using the machine learning control program, generate, using the machine learning control program, an output based on the sensor data, the output including one or more field weakening parameters, and control the motor based on the generated output.
    Type: Application
    Filed: June 10, 2024
    Publication date: December 5, 2024
    Inventors: Jonathan E. Abbott, Alexander T. Huber
  • Patent number: 12087394
    Abstract: A memory device includes a command interface configured to receive write commands from a host device. Additionally, the memory device includes an input buffer configured to buffer a strobe signal from the host device. Furthermore, the memory device includes a first ripple counter and a second ripple counter. The memory device includes command handling circuitry configured to alternatingly start the first ripple counter and the second ripple counter in response to consecutive write commands. The command handling circuitry and/or the first and second ripple counters are configured to suppress a reset of the input buffer if either the first ripple counter or the second ripple counter has not reached a threshold and is still counting.
    Type: Grant
    Filed: September 8, 2022
    Date of Patent: September 10, 2024
    Assignee: Micron Technology, Inc.
    Inventors: Brian W. Huber, Scott E. Smith, Gary L. Howe
  • Patent number: 12076383
    Abstract: Provided are methods for sensitizing gastrin-associated tumors and/or cancers in subjects to inducers of humoral and cellular immune responses. In some embodiments, the methods relate to administering compositions that have anti-gastrin antibodies, gastrin peptides, and/or nucleic acids that inhibit expression of gastrin gene products to subjects. Also provided are methods for preventing, reducing, and/or eliminating the formation of fibroses associated with tumors and/or cancers, and methods for treating gastrin-associated tumors and/or cancers that include administering to subjects in need thereof a first agent that provides and/or induces an anti-gastrin humoral or cellular immune response in the subject and a second agent that includes one or more stimulators of cellular immune responses against the tumors and/or cancers.
    Type: Grant
    Filed: November 18, 2022
    Date of Patent: September 3, 2024
    Assignee: Cancer Advances Inc.
    Inventors: Lynda Sutton, Jill P. Smith, Nicholas Osborne, Brian E. Huber, Allen Cato
  • Patent number: 12064289
    Abstract: The present invention is a method, system, and apparatus used to transmit information to an individual and or receiver who is not located at the actual ultrasound procedure that may monitor, communicate, and assist in the procedure in real time as well as provide protocols for specific procedures; wherein the ultrasound machine communicates to a receiver operational information such as but not limited to audio, visual, performance, and so forth; wherein the information may be received in real time to another party not located at the site of the procedure who may assist with the procedure, training, protocols, and so forth; and wherein the receiver may then transmit back to the ultrasound machine specific directions as well as communicate with the ultrasound operator.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: August 20, 2024
    Assignee: Oncura Partners Diagnostics LLC
    Inventors: Brian J. Huber, Craig E. Presnall
  • Patent number: 11965163
    Abstract: The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Grant
    Filed: September 28, 2021
    Date of Patent: April 23, 2024
    Assignee: MiNA Therapeutics Limited
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Monika Krampert, Markus Hossbach
  • Publication number: 20240035026
    Abstract: The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: September 28, 2021
    Publication date: February 1, 2024
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Monika Krampert, Markus Hossbach
  • Publication number: 20240018519
    Abstract: The invention relates to modified oligonucleotides, e.g., saRNAs useful in upregulating the expression of a target gene and therapeutic compositions comprising such oligonucleotides. Methods of using the oligonucleotides and the therapeutic compositions are also provided.
    Type: Application
    Filed: April 12, 2023
    Publication date: January 18, 2024
    Applicant: MiNA Therapeutics Limited
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Vikash Reebye
  • Patent number: 11745715
    Abstract: A brake cylinder maintaining system that combines a brake cylinder maintaining check valve and a quick service limiting valve into a single unit to have lower hysteresis, and thus more precise BCM regulation pressure and a smaller pressure offset. The check valve and quick service valve are coupled to provide a single system having multiple valve seats for selective communication between quick service pressure and brake cylinder pressure on one hand, and between a brake cylinder maintaining pressure and brake cylinder pressure on the other hand.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: September 5, 2023
    Assignee: NEW YORK AIR BRAKE, LLC
    Inventors: Derick Call, Howard E. Huber, Jr., Brian Graves
  • Publication number: 20230226422
    Abstract: A portable game where balls are rolled over a ramp at targets. The game incorporates aspects of bocce ball with the additional challenge of a ramp and different types of targets. The game can roll up into an easily transportable package with all game pieces stored inside the roll. The roll can then be deployed to act as a portion of the game's playing surface in any suitable location. The game consists of balls, a runner, a ramp, and different forms of targets. The runner could be made of slats, fabric, or other materials that are flexible and can be rolled. The balls are similar to bocce balls but could be lighter or smaller for easy transport.
    Type: Application
    Filed: January 16, 2023
    Publication date: July 20, 2023
    Inventors: Nicole M. Hageman, Zach E. Huber, Claude P. Drehfal, Ben J. Fisher
  • Publication number: 20230086898
    Abstract: Provided are methods for sensitizing gastrin-associated tumors and/or cancers in subjects to inducers of humoral and cellular immune responses. In some embodiments, the methods relate to administering compositions that have anti-gastrin antibodies, gastrin peptides, and/or nucleic acids that inhibit expression of gastrin gene products to subjects. Also provided are methods for preventing, reducing, and/or eliminating the formation of fibroses associated with tumors and/or cancers, and methods for treating gastrin-associated tumors and/or cancers that include administering to subjects in need thereof a first agent that provides and/or induces an anti-gastrin humoral or cellular immune response in the subject and a second agent that includes one or more stimulators of cellular immune responses against the tumors and/or cancers.
    Type: Application
    Filed: November 18, 2022
    Publication date: March 23, 2023
    Applicant: Cancer Advances Inc.
    Inventors: Lynda Sutton, Jill P. Smith, Nicholas Osborne, Brian E. Huber, Allen Cato
  • Patent number: 11583576
    Abstract: Provided are methods for sensitizing gastrin-associated tumors and/or cancers in subjects to inducers of humoral and cellular immune responses. In some embodiments, the methods relate to administering compositions that have anti-gastrin antibodies, gastrin peptides, and/or nucleic acids that inhibit expression of gastrin gene products to subjects. Also provided are methods for preventing, reducing, and/or eliminating the formation of fibroses associated with tumors and/or cancers, and methods for treating gastrin-associated tumors and/or cancers that include administering to subjects in need thereof a first agent that provides and/or induces an anti-gastrin humoral or cellular immune response in the subject and a second agent that includes one or more stimulators of cellular immune responses against the tumors and/or cancers.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: February 21, 2023
    Assignee: Cancer Advances Inc.
    Inventors: Lynda Sutton, Jill P. Smith, Nicholas Osborne, Brian E. Huber, Allen Cato
  • Publication number: 20230031703
    Abstract: The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: August 10, 2022
    Publication date: February 2, 2023
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Vikash Reebye
  • Patent number: 11447773
    Abstract: The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: September 20, 2022
    Assignee: MINA THERAPEUTICS LIMITED
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Vikash Reebye
  • Publication number: 20220090074
    Abstract: The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: September 28, 2021
    Publication date: March 24, 2022
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Monika Krampert, Markus Hossbach
  • Patent number: 11162099
    Abstract: The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: November 2, 2021
    Assignee: MINA THERAPEUTICS LIMITED
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Monika Krampert, Markus Hossbach
  • Publication number: 20210187007
    Abstract: The invention relates to saRNA targeting a C/EBP? transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: December 9, 2020
    Publication date: June 24, 2021
    Inventors: Andreas Wagner, Robert Habib, Hans E. Huber, Pål Saetrom, Endre Bakken Stovner, Markus Hossbach, Monika Krampert, Hans-Peter Vornlocher
  • Publication number: 20210139010
    Abstract: A brake cylinder maintaining system that combines a brake cylinder maintaining check valve and a quick service limiting valve into a single unit to have lower hysteresis, and thus more precise BCM regulation pressure and a smaller pressure offset. The check valve and quick service valve are coupled to provide a single system having multiple valve seats for selective communication between quick service pressure and brake cylinder pressure on one hand, and between a brake cylinder maintaining pressure and brake cylinder pressure on the other hand.
    Type: Application
    Filed: January 25, 2021
    Publication date: May 13, 2021
    Applicant: NEW YORK AIR BRAKE, LLC
    Inventors: Derick Call, Howard E. Huber, JR., Brian Graves
  • Patent number: 10926751
    Abstract: A brake cylinder maintaining system that combines a brake cylinder maintaining check valve and a quick service limiting valve into a single unit to have lower hysteresis, and thus more precise BCM regulation pressure and a smaller pressure offset. The check valve and quick service valve are coupled to provide a single system having multiple valve seats for selective communication between quick service pressure and brake cylinder pressure on one hand, and between a brake cylinder maintaining pressure and brake cylinder pressure on the other hand.
    Type: Grant
    Filed: August 10, 2018
    Date of Patent: February 23, 2021
    Assignee: New York Air Brake LLC
    Inventors: Derick Call, Howard E. Huber, Jr., Brian Graves
  • Patent number: 10912790
    Abstract: The invention relates to saRNA targeting a C/EBP? transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: February 9, 2021
    Assignee: MiNA THERAPEUTICS LIMITED
    Inventors: Andreas Wagner, Robert Habib, Hans E. Huber, Pål Sætrom, Endre Bakken Stovner, Markus Hossbach, Monika Krampert, Hans-Peter Vornlocher